Highlights of 2019
Please click the links below to go to the CSF review of each paper
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Please click the links below to go to the CSF review of each paper
Clin Pharmacol Ther . 2020 Apr;107(4):994-1003. doi: 10.1002/cpt.1671.
Arthritis Rheumatol .2019 Sep;71(9):1450-1459. doi: 10.1002/art.40911. Epub 2019 Aug 6.
Arthritis Care Res (Hoboken) 2019;71(10):1387–95
J Clin Med. 2019 Sep 5;8(9). pii: E1394
Ann Rheum Dis 2019 DOI: 10.1136/annrheumdis-2019-215164
JAMA 2019 322(4):315-325
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
Ann Rheum Dis 2019 DOI: 10.1136/annrheumdis-2019-215764
Lancet 2019;394:576–86. doi: 10.1016/S0140-6736(19)30952-3
Treatment with risankizumab showed significantly greater efficacy over adalimumab in providing substantial skin clearance in patients with moderate-to-severe chronic plaque PsO. This study aimed to assess the safety and efficacy of risankizumab compared with adalimumab in an active-comparator Phase 3 trial.